Ronacaleret Uses, Dosage, Side Effects and more
Ronacaleret is a calcium-sensing receptor antagonist.
| Trade Name | Ronacaleret |
| Generic | Ronacaleret |
| Ronacaleret Other Names | Ronacaleret |
| Type | |
| Formula | C25H31F2NO4 |
| Weight | Average: 447.523 Monoisotopic: 447.222114808 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Post-menopausal women with osteoporosis
How Ronacaleret works
751689 is novel small molecules that work by antagonizing calcium-sensing receptors on the surface of the parathyroid gland, thereby triggering a transient release of the body's own stores of parathyroid hormone (PTH). This release of PTH may have the potential to rebuild the bone mass lost as a result of osteoporosis and improve overall bone microarchitecture in these patients.
